RNL Bio Co., Ltd.
Records under this name other than the patents RNL Bio Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 6 of 6 · Back to RNL Bio Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,807,461 | Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same Term ended Term ended Jun 25, 2026 · From the USPTO record | Term ended | Term ended Jun 25, 2026 | From the USPTO record |
| US 8,911,802 | Composition for increasing milk production containing Artemisia capillaris Lapsed on the fee record Ended Dec 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 16, 2022 | From the USPTO record |
| US 8,808,682 | Method for inducing migration of adipose-derived adult stem cells Lapsed on the fee record Ended Aug 19, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2022 | From the USPTO record |
| US 7,687,062 | Method for diagnosing colon cancer Lapsed on the fee record Ended Mar 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2022 | From the USPTO record |
| US 8,470,378 | Anti-influenza viral composition containing bark or stem extract of Alnus japonica Lapsed on the fee record Ended Jun 25, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 25, 2021 | From the USPTO record |
| US 9,211,306 | Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose Lapsed on the fee record Ended Dec 15, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 15, 2019 | From the USPTO record |